Axsome Therapeutics, Inc. has grown revenue 62% a year over three years and 134% a year over five. Revenue growth, 3-year annual rate: +62% (Biotechnology median +21%). Revenue growth, 5-year rate: +134%, growth has slowed since the five-year average. Years of annual history on file: 12, FY2014 to FY2025, as filed.

AXSMAxsome Therapeutics, Inc.

HealthcareUSD

$207.10

$103.9652 weeks$255.17

Is it growing?

Is AXSM growing?

Axsome Therapeutics, Inc. has grown revenue 62% a year over three years and 134% a year over five.

+62%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +134%
Revenue growth, 5-year rate · +62% over three · growth has slowed since the five-year average
Years of annual history on file: 12
Years of annual history on file · FY2014 to FY2025, as filed

Details›